Life SciencesRSS

  • September 18, 2007

    ICU Medical Prevails In IV Patent Dispute

    A district court judge granted summary judgment of non-infringement to ICU Medical Inc. on Friday, finding that the company’s needle-free intravenous connector does not infringe rival Medegen MMS Inc.’s patent.

  • September 19, 2007

    Encysive Wins Dismissal Of Securities Suit

    A federal judge has dismissed a proposed class action lawsuit that accused Encysive Pharmaceuticals Inc. of misleading investors about the prospects for its pulmonary arterial hypertension treatment Thelin.

  • September 17, 2007

    J&J, Angiotech Reach Accord Over Stent Patents

    Johnson & Johnson subsidiary Conor Medsystems has reached a settlement with Angiotech Pharmaceuticals Inc. to resolve litigation regarding drug-eluting stents used in cancer chemotherapy.

  • September 17, 2007

    Judge Rejects Lipodissolve Ban

    A state court has thwarted a Kansas ban that would have prohibited most physicians from carrying out a procedure that shrinks down patients’ body fat.

  • September 13, 2007

    Judge Sends Two AWP Cases Home

    A judge in the average wholesale price multidistrict litigation has agreed to move suits brought by the states of Nevada and Montana back to the states' federal courts.

  • September 13, 2007

    Sans Injunction, Open Season For Generic Protonix

    Altana Pharma AG has lost another bulwark against competition for its hit ulcer and heartburn drug Protonix, now that the stays that went into effect in 2005 have expired and a judge has declined to block Sun Pharmaceuticals Industries Ltd. and Teva Pharmaceutical Industries Ltd. from marketing generics.

  • September 13, 2007

    Canadian Court Upholds Lipitor In Crystal Form

    A federal court in Canada has ruled that Pfizer Inc.’s patent covering the key ingredient in Lipitor would be infringed by Ranbaxy Laboratories Ltd.’s method for developing a generic copy of the cholesterol-lowering drug.

  • September 13, 2007

    Judge Upholds BofA Victory In Patent Suit

    Bank of America NA has been handed a victory in a long-running lawsuit, with a district court judge declining to toss a jury verdict declaring TradeCard Inc.'s patent for a purchase order processing system invalid.

  • September 12, 2007

    Teva, Dr. Reddy's Settle Generic Zoloft Dispute

    Israeli drug company Teva Pharmaceutical Industries Ltd. has reached an agreement with Dr. Reddy’s Laboratories Inc. and agreed to drop a patent infringement suit filed against the Indian drug maker over its generic version of the antidepressant Zoloft.

  • September 12, 2007

    Apotex Suffers Defeat In Acular Dispute

    In a major setback for Apotex Inc., a federal judge has found that the Canadian drug maker’s application for a generic version of anti-inflammatory eye treatment Acular infringed a patent held by Roche Palo Alto LLC and licensed to Allergan LLC.

  • September 11, 2007

    Biovail Settles With BofA, Trader In Conspiracy Case

    Canadian drug maker Biovail Inc. has reached a settlement with Banc of America Securities LLC and one of the bank's former traders, agreeing to drop claims against them from a lawsuit accusing several hedge funds and brokers of conspiring to drive down its stock price.

  • September 10, 2007

    Sanofi-Aventis Pays $190M To Settle Drug Price Case

    French drug giant Sanofi-Aventis will hand over more than $190 million to settle claims by the U.S. Department of Justice and various states that its predecessor defrauded Medicare by inflating the reported average wholesale price of a cancer drug.

  • September 10, 2007

    Judge OKs Settlement In Drug Securities Case

    A judge has given his final approval to a $52.5 million settlement agreement in two related securities cases filed against pharmaceutical company Sepracor Inc. over the company's alleged concealment of safety concerns about its antihistamine drug, Soltara.

  • September 10, 2007

    ImClone To Pay $65M To End Erbitux Suit

    ImClone Systems Inc. will shell out $65 million as part of a settlement with Repligen Corp. and the Massachusetts Institute of Technology to resolve Repligen and MIT's 2004 patent suit against Imclone over its cancer treatment Erbitux.

  • September 7, 2007

    Eli Lilly Settles With Doctor Over Zyprexa Leaks

    Drug maker Eli Lilly & Co. has reached a settlement with a doctor who breached a protective order after handing over confidential documents to a plaintiffs' lawyer in the Zyprexa product liability litigation.

  • September 7, 2007

    Enzo Appeals Loss In DNA Detection Patent Suit

    Enzo Biochem Inc. has appealed a court’s decision to grant Applera Corp.’s summary judgment motion of invalidity in a patent infringement suit over DNA detection technology.

  • September 6, 2007

    Judge OKs Insider Trading Settlement In Drug Case

    The wife of the former CEO of Cubist Pharmaceuticals, her brother and his neighbor have settled insider trading allegations brought by the U.S. Securities and Exchange Commission regarding the company's common stock.

  • September 6, 2007

    Nationwide Class For Vioxx Suit Rejected

    Handing Merck & Co. a victory, the New Jersey Supreme Court on Thursday reversed a lower court ruling that certified a nationwide class of Vioxx consumers attempting to get back the money they spent on the drug.

  • September 5, 2007

    Ortho-McNeil Spars With Makers Of Ultracet Generic

    Drug-maker Ortho-McNeil Inc. has been fighting with generic makers Barr Laboratories Inc. and Caraco Pharmaceutical Laboratories Ltd. over its request to vacate a summary judgment ruling in the dispute over its patent for the painkiller Ultracet.

  • September 5, 2007

    Lexapro Patent Upheld On Appeal

    A federal appeals court panel has upheld both the validity of Forest Laboratories Inc.’s patent on the blockbuster antidepressant drug Lexapro and an injunction thwarting Ivax Pharmaceuticals Corp.’s plans to market a generic.